Sa’ad’s Reading List
January 31, 2022 No Comments
Noetic Fund’s Sa’ad Shah is often asked for his favourite books on entheogens and the complex workings of our psyche. We would like to share
Home
OVERVIEW
Noetic Fund
Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system.
About
no•et•ic
“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”
Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.
Mission
Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience.
Commitment
We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations.
Focus
CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.
Investment
Our Portfolio
Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies. Below is a selection of companies we have invested in.
Fund I
Fund II
Corporate VIDEOS
Our Company and Team
Meet The Team
Our Team
Sa'ad Shah
Managing Partner
9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading
9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak
BA in Economics and Political Science from Columbia University.
Warren Wright
Managing Partner
9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments
12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer
Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group.
Craig Hippern
CFO & COO
25+ years in the onshore and offshore investment industry
10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company
8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence
CPA,CA (Canada) and CPA(IL) (U.S.A.)
Richard Cheung, B.Sc.Phm., Ph.D., LL.B.
General Counsel
15+ years advising clients ranging from start-ups to multinational corporations on intellectual property and regulated health products at firms including Fasken, Ogilvy Renault, and Bereskin & Parr
Licensed pharmacist in the Province of Ontario with experience in community and hospital pharmacy
LL.B. from Western University
Ph.D. in Pharmaceutical Sciences and B.Sc.Phm. (Pharmacy) from the University of Toronto
Registered Patent Agent and Trademark Agent in Canada
Preetha Nooyi
Principal, Business Development USA
8 years of experience across M&A, innovation, consumer insights, and product development roles in the consumer-packaged goods sector
Co-developed the investment thesis and strategic framework to screen potential CPG acquisitions and investments at Lindsay Goldberg
5 years of training and class facilitation in leadership development at Yale School of Management
MBA from Yale School of Management
BA from Hamilton College
Sri Teja Mullapudi, PhD
Principal, Fund Investments, Scientific Lead
Helped raise and deploy $60M+ in the psychedelic and neuroscience sectors to improve mental healthcare
Experienced in life sciences investment opportunity analyses from TIAP (MaRS Innovation)
8+ years of research experience with 8 publications in peer-reviewed journals
Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany
M.Tech + B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India
Soccer player with TSV Rödgen, Germany (2014-18), Toronto City FC, Canada (2019-21)
David Schnarr
CCO & Head of Operations
20+ years at Maple Financial Group Inc., serving in a variety of senior finance, compliance and administrative functions
2 years as CFO and CCO at Clearpool Execution Services Canada. Started IIROC-regulated broker-dealer from the beginning. (Company was purchased by BMO in 2020)
Professional designations: CPA, CMA (Canada) and CFA
Daria Zhukova
Senior Associate, Administration & Accounting
3+ years of experience in business operations and office administration.
Managed financial accounting for multimillion-dollar corporations, including companies operating in the medical and pharmaceutical industries.
BA in Economics and Mathematics from the University of British Columbia, with one year of study at the National University of Singapore, focusing on financial markets and macroeconomics
Matthew Baggott, PhD
Venture Partner
CEO of Tactogen
30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development
Bachelor’s degree in Philosophy and Post-doctoral Fellow at the University of Chicago
Ph.D. in Neuroscience from the University of California, Berkeley.
Jeffrey Becker, MD
Venture Partner
CSO & Co-Founder of Bexson Biomedical, Inc.
Board-certified in Psychiatry and Integrative & Holistic Medicine
Leader in applied genetics and functional nutrient science in mental health
Ketamine assisted psychotherapy trainer and opinion leader
UC Berkeley Bachelor’s in Biology, Entomology & Religious Mysticism; UCLA Medical graduate & psychiatric resident
David Rabin, MD, PhD
Venture Partner
CIO of Apollo Neuroscience
Board-certified psychiatrist, neuroscientist, tech entrepreneur & inventor
Operates a clinical psychiatry practice and conducting research on the epigenetic regulation of trauma responses and recovery
Graduate degrees from Albany Medical College and psychiatric residency from Pittsburgh Medical Center.
Marine Mallinson
Venture Advisor
Seasoned tech entrepreneur with two exits, a business data platform with global footprint (GIA) and an Asia wide business expert platform (Fusion).
Board member and investor in mental health companies
Previously, co-founder CEO of a gamified and AI powered social network for cancer patients in China and a video Q&A platform.
Ex-investment banker in Tokyo and managed the editorial team of a Japanese publishing house.
MSc in Economics and Finance from Sciences Po Paris (Paris Institute of Political Studies) and BA in Japanese studies from INALCO Paris
Prof. Ede Frecska, PhD
Advisor
Chairman of Psychiatry at the Faculty of Medicine of the University of Debrecen
Residency training in Psychiatry both in Hungary (1986), and in the United States (1992)
Qualified psychopharmacologist (1987) of international merit
17 years of clinical and research experience in the United States.
Marci Freedman
Advisor
25+ years of lifestyle marketing experience with companies including Reebok and Vitaminwater.
8 years developing, executing and implementing national programs which helped define and build the Vitaminwater and Smartwater brands.
Advisory Board member of Cloud Water Brands, Gem&Bolt Mezcal and Prosper Technologies Holdings to name a few.
Adventurer, Explorer, and World Traveler.
Vanessa Levi
Advisor
9 years at Russell Investments – Head of Italy, helped build AUM to $8B and opened Milan office
6 years as Managing Partner of a single family office investing across all asset classes
6 years in healthcare research and consultancy at Datamonitor and Frost & Sullivan
BA Hon in Business Administration from European Business School in London
Victor Mifsud
Advisor
10+ years in the psychedelic/health optimization space. Founder of the Vision Optimization Summit.
Recently completed a feature-length documentary film called “My Neuroplastic Adventure“.
Worked/mentored with renowned national best-selling author and physician Dr. Gabor Maté, Dr. Lara Boyd, and Dr. Norman Doidge to name a few.
Ryerson University – New Media & Film
Jody Levy
Advisor
Jody Levy is an artist, designer, director, entrepreneur, executive and investor.
Jody is the founder, creative director and Chief Executive Officer of a handful of companies dedicated to empowering people to be as healthy and happy as possible.
Luis Eduardo Luna, PhD
Advisor
Guggenheim Fellow (1986), Fellow of the Linnaean Society of London (1989), and Doctor Honoris Causa, from St. Lawrence, Canton, New York (2002)
Ph.D. from the Department of Comparative Religion Stockholm University (1989)
Master from Oslo University (1980)
B.A. from Madrid University (1972).
Press
Previous
Next
BLOG PoSTS
Read More »
Subscribe
Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space
CONTACT US
Who to Contact
Do you have a question about our Fund?
Please feel free to get in touch by sending us an email to [email protected].
Do you have a question about your investment?
Please feel free to get in touch by sending us an email to [email protected].
Do you want the Fund to invest in your company?
Please feel free to get in touch by sending us an email to [email protected].
